Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan.

Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, Muirhead DE, Kunz S, Moore SA, Iannaccone ST, Miyake K, McNeil PL, Mayer U, Oldstone MB, Faulkner JA, Campbell KP.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12573-9. doi: 10.1073/pnas.0906545106. Epub 2009 Jul 24.

2.

Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse.

Ross J, Benn A, Jonuschies J, Boldrin L, Muntoni F, Hewitt JE, Brown SC, Morgan JE.

Stem Cells. 2012 Oct;30(10):2330-41. doi: 10.1002/stem.1197.

3.

Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury.

Gumerson JD, Kabaeva ZT, Davis CS, Faulkner JA, Michele DE.

Am J Physiol Cell Physiol. 2010 Dec;299(6):C1430-40. doi: 10.1152/ajpcell.00192.2010. Epub 2010 Sep 15.

4.

Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function.

Kabaeva Z, Meekhof KE, Michele DE.

Hum Mol Genet. 2011 Sep 1;20(17):3346-55. doi: 10.1093/hmg/ddr240. Epub 2011 May 30.

5.

Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.

Kanagawa M, Nishimoto A, Chiyonobu T, Takeda S, Miyagoe-Suzuki Y, Wang F, Fujikake N, Taniguchi M, Lu Z, Tachikawa M, Nagai Y, Tashiro F, Miyazaki J, Tajima Y, Takeda S, Endo T, Kobayashi K, Campbell KP, Toda T.

Hum Mol Genet. 2009 Feb 15;18(4):621-31. doi: 10.1093/hmg/ddn387. Epub 2008 Nov 18.

6.

Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.

Gawlik KI, Mayer U, Blomberg K, Sonnenberg A, Ekblom P, Durbeej M.

FEBS Lett. 2006 Mar 20;580(7):1759-65. Epub 2006 Feb 21.

7.

Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.

Cohn RD, Mayer U, Saher G, Herrmann R, van der Flier A, Sonnenberg A, Sorokin L, Voit T.

J Neurol Sci. 1999 Mar 1;163(2):140-52.

PMID:
10371075
8.

Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.

Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP.

Nature. 2002 Jul 25;418(6896):417-22.

PMID:
12140558
9.

Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.

Hara Y, Kanagawa M, Kunz S, Yoshida-Moriguchi T, Satz JS, Kobayashi YM, Zhu Z, Burden SJ, Oldstone MB, Campbell KP.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17426-31. doi: 10.1073/pnas.1114836108. Epub 2011 Oct 10.

10.

Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction.

Brown SC, Fassati A, Popplewell L, Page AM, Henry MD, Campbell KP, Dickson G.

J Cell Sci. 1999 Jan;112 ( Pt 2):209-16.

11.

The sarcolemma in the Large(myd) mouse.

Reed PW, Mathews KD, Mills KA, Bloch RJ.

Muscle Nerve. 2004 Nov;30(5):585-95.

PMID:
15389724
12.

[Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders].

Toda T.

Rinsho Shinkeigaku. 2009 Nov;49(11):859-62. Review. Japanese.

PMID:
20030231
13.

The role of defective glycosylation in congenital muscular dystrophy.

Schachter H, Vajsar J, Zhang W.

Glycoconj J. 2004;20(5):291-300. Review.

PMID:
15229394
14.

Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes.

Dickson G, Azad A, Morris GE, Simon H, Noursadeghi M, Walsh FS.

J Cell Sci. 1992 Dec;103 ( Pt 4):1223-33.

16.

Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.

Saito F, Blank M, Schröder J, Manya H, Shimizu T, Campbell KP, Endo T, Mizutani M, Kröger S, Matsumura K.

FEBS Lett. 2005 Apr 25;579(11):2359-63.

17.

Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Martin PT, Shelton GD, Dickinson PJ, Sturges BK, Xu R, LeCouteur RA, Guo LT, Grahn RA, Lo HP, North KN, Malik R, Engvall E, Lyons LA.

Neuromuscul Disord. 2008 Dec;18(12):942-52. doi: 10.1016/j.nmd.2008.08.002. Epub 2008 Nov 5.

18.

[Dystroglycan linkage and muscular dystrophy].

Shimizu T.

Rinsho Shinkeigaku. 2002 Nov;42(11):1091-4. Review. Japanese.

PMID:
12784674
19.

Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.

Yoshida-Moriguchi T, Campbell KP.

Glycobiology. 2015 Jul;25(7):702-13. doi: 10.1093/glycob/cwv021. Epub 2015 Apr 16. Review.

20.

Disruption of sarcolemmal dystrophin and beta-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis.

Celes MR, Torres-Dueñas D, Malvestio LM, Blefari V, Campos EC, Ramos SG, Prado CM, Cunha FQ, Rossi MA.

Lab Invest. 2010 Apr;90(4):531-42. doi: 10.1038/labinvest.2010.3. Epub 2010 Feb 8.

Supplemental Content

Support Center